AIM Will Launch Value and Biotech Funds
Abel Garcia and Michael Yellen will manage the Global Biotech fund, while Matthew Seinsheimer and Bret Stanley will have responsibility for the Mid Cap Basic Value fund. Seinsheimer and Stanley already manage the stock side of AIMs Basic Balanced fund, launched Oct. 1.
According to published reports, an AIM spokesman declined to say when the new funds would be launched.